LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 148 filers reported holding LEMAITRE VASCULAR INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $182 | +68.5% | 2,221 | +34.4% | 0.00% | – |
| Q1 2024 | $108 | +10.2% | 1,653 | -4.5% | 0.00% | – |
| Q4 2023 | $98 | -82.7% | 1,731 | -83.4% | 0.00% | -100.0% |
| Q3 2023 | $568 | -1.9% | 10,450 | +21.1% | 0.00% | 0.0% |
| Q2 2023 | $579 | -98.9% | 8,628 | +740.9% | 0.00% | – |
| Q3 2022 | $51,000 | -56.0% | 1,026 | -60.0% | 0.00% | – |
| Q2 2022 | $116,000 | +45.0% | 2,563 | +48.8% | 0.00% | – |
| Q1 2022 | $80,000 | -7.0% | 1,722 | 0.0% | 0.00% | – |
| Q4 2021 | $86,000 | +4.9% | 1,722 | +10.9% | 0.00% | – |
| Q3 2021 | $82,000 | -18.0% | 1,553 | -5.4% | 0.00% | – |
| Q2 2021 | $100,000 | +25.0% | 1,641 | 0.0% | 0.00% | – |
| Q1 2021 | $80,000 | +70.2% | 1,641 | +38.8% | 0.00% | – |
| Q4 2020 | $47,000 | -4.1% | 1,182 | -37.3% | 0.00% | – |
| Q2 2020 | $49,000 | – | 1,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |